AtriCure
$37.43
24H
Market Cap
Volume
Supply
Price Chart
About AtriCure - ATRC
AtriCure, Inc. is a medical device company that provides innovative solutions designed to decrease the global Afib epidemic, primarily focused on developing, manufacturing, and selling devices to treat atrial fibrillation and related conditions. Their product line includes a variety of minimally invasive ablation devices and access tools to facilitate cardiac tissue ablation procedures.
What are AtriCure's core values and mission statement?
AtriCure, Inc.'s mission is to provide innovative electrosurgery tools to improve the quality of life and health of patients with atrial fibrillation. Their core values focus on innovation, teamwork, accountability, and a commitment to patients which drives their pursuit of excellence in developing surgical treatments for atrial fibrillation and related conditions.
Who founded AtriCure and when?
AtriCure, Inc. was founded by Dr. Elizabeth D. Krell and Dr. Alan Mark Able in 2000.
Who leads AtriCure?
As of the latest available information before your specified restrictions, Michael Carrel is the President and CEO of AtriCure, Inc. However, for the most current leadership information, please refer to the company's official communications or website.
Where is AtriCure located, and what is its base country?
AtriCure, Inc. is headquartered in Mason, Ohio, and its base country is the United States.
On which exchanges is AtriCure traded?
AtriCure, Inc. is traded on the NASDAQ stock exchange under the ticker symbol ATRC.
Historical data
AtriCure (ATRC) Price Live Data
The live price of AtriCure (ATRC) is $37.43, with a trading volume of 269,508 in the last 24 hours. Wrapstocks updates the ATRC price in real-time. AtriCure is up 0.19% in the last 24 hours. The company has a live market cap of $1,824,836,096.00 and a supply of 48,753,302 ATRC stocks.
AtriCure (ATRC) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 41 minutes.
